Facilitated By

San Antonio Medical Foundation

Trending Research

Top viewed research performed by San Antonio Bioscience Organizations


This Phase II STTR project furthers the development of KIOS, a digital therapeutic for the treatment of opioid use disorder (OUD). The product to be commercialized is an FDA-approved digital therapeutic (DTx) medical device offered adjunctive to medication assisted therapy (MAT). In contrast to other digital products for OUD, only KIOS offers continuously available, individualized, evidence-based behavioral intervention strategies responsive to a patient's current clinical status outside the context of the doctor’s office or treatment facility.

Biomedical Development Corporation
Jennifer Sharpe Potter, Ph.D.

The primary objective of this study is to determine the safety and effectiveness of AmnioFix Injectable as compared to the 0.9% Sodium Chloride Injection, USP placebo control for the treatment of knee osteoarthritis.

Brooke Army Medical Center
Email for information